Exploiting the Feedstock Flexibility of the Emergent Synthetic Biology Chassis for Engineered Natural Product Production
Overview
Pharmacology
Affiliations
A recent goal of synthetic biology has been to identify new chassis that provide benefits lacking in model organisms. is a marine Gram-negative bacterium which is an emergent synthetic biology chassis with inherent benefits: An extremely fast growth rate, genetic tractability, and the ability to grow on a variety of carbon sources ("feedstock flexibility"). Given these inherent benefits, we sought to determine its potential to heterologously produce natural products, and chose beta-carotene and violacein as test cases. For beta-carotene production, we expressed the beta-carotene biosynthetic pathway from the sister marine bacterium , as well as the mevalonate biosynthetic pathway from the Gram-positive bacterium to improve precursor abundance. Violacein was produced by expressing a biosynthetic gene cluster derived from . Not only was able to heterologously produce these compounds in rich media, illustrating its promise as a new chassis for small molecule drug production, but it also did so in minimal media using a variety of feedstocks. The ability for to produce natural products with multiple industrially-relevant feedstocks argues for continued investigations into the production of more complex natural products in this chassis.
A dual-inducible control system for multistep biosynthetic pathways.
Carrillo Rincon A, Cabral A, Gyorgy A, Farny N J Biol Eng. 2024; 18(1):68.
PMID: 39568033 PMC: 11580509. DOI: 10.1186/s13036-024-00462-z.
Microbial Cell Factories in the Bioeconomy Era: From Discovery to Creation.
Yan X, He Q, Geng B, Yang S Biodes Res. 2024; 6:0052.
PMID: 39434802 PMC: 11491672. DOI: 10.34133/bdr.0052.
Forsten E, Gerdes S, Petri R, Buchs J, Magnus J BMC Biotechnol. 2024; 24(1):63.
PMID: 39313794 PMC: 11421182. DOI: 10.1186/s12896-024-00897-8.
Fuchs H, Ullrich S, Hedrich S Sci Rep. 2024; 14(1):6093.
PMID: 38480761 PMC: 10937671. DOI: 10.1038/s41598-024-54097-7.
Exploration of the In Vitro Violacein Synthetic Pathway with Substrate Analogues.
Hooe S, Thakur M, Lasarte-Aragones G, Breger J, Walper S, Medintz I ACS Omega. 2024; 9(3):3894-3904.
PMID: 38284012 PMC: 10809250. DOI: 10.1021/acsomega.3c08233.